Ubs Asset Management Americas Inc Cogent Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 135,604 shares of COGT stock, worth $970,924. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,604
Previous 117,863
15.05%
Holding current value
$970,924
Previous $1.27 Million
16.9%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding COGT
# of Institutions
190Shares Held
104MCall Options Held
157KPut Options Held
439K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$65.2 Million4.5% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$52.2 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$49.9 Million8.87% of portfolio
-
Commodore Capital LP New York, NY6.88MShares$49.3 Million5.38% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA6.23MShares$44.6 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $471M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...